Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 31, 2011


Agilent Technologies has appointed Sam Mohan to be Southeast Asia regional manager for its Life Sciences Group. Mohan will be responsible for building and implementing the firm's Southeast Asian product strategies, as well as its lifecycle management, partner integration, global branding, and communications. He formerly was sales director of Cell Biosciences. Before that, he was a manager at Amersham Biosciences (now part of GE Healthcare) and Bio-Rad Laboratories.

Raymond Whitaker will not stand for his position on Fluidigm's board of directors at the firm's next annual stockholder meeting. The company's board also has approved an increase in base salary for President and CEO Gajus Worthington from $319,000 to $350,000.

RainDance Technologies has tapped Andy Watson to serve as its vice president and chief marketing officer. In the role, he will lead marketing and strategy efforts for the company's targeted sequencing business and for the launch of its digital PCR and single cell analysis products.

Watson formerly was VP of SOLiD sequencing product management at Life Technologies. He was also was a founder of Quantum Dot, and he led development of technologies and software for large-scale DNA analysis at Sequana Therapeutics.

Adarza BioSystems has added Heiner Dreismann and James Senall to its board of directors. Dreismann formerly was CEO of Roche Molecular Systems, while Senall formerly served as managing director of business development at the Greater Rochester Enterprise.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.